Cecilia Pessoa Gingerich

Articles

FDA Grants Alzheimer Biomarker Test Breakthrough Status

July 21, 2018

The FDA has granted a Breakthrough Device Designation to the Elecsys beta-Amyloid (1-42) and Elecsys Phospho-Tau (181P) cerebrospinal fluid assays, which can be used in the diagnosis of Alzheimer disease.